MarketWatch: Biotechnology

MarketWatch: Biotechnology
  • Report price : $ 200
  • Publication date : June 2008
  • Length : 31 pages

Get this Report Now !

MarketWatch: Biotechnology

Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Biotechnology industry.

RELATED REPORTS

MarketWatch: CNS

MarketWatch: CNS

  • $ 200
  • June 2008
  • 30 pages

Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in theCN ...

Industries : Pharmaceutical

MarketWatch: Cancer

MarketWatch: Cancer

  • $ 200
  • June 2008
  • 26 pages

Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the major current business issues and events, including R&D news, licensing deals, alliances and joint ventu ...

Industries : Pharmaceutical

MarketWatch: Health Round-up

MarketWatch: Health Round-up

  • $ 400
  • June 2008
  • 62 pages

Datamonitor's MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory an ...

Industries : Pharmaceutical

Contract Manufacturing Strategies: Market developments, technology transfer and key success factors

Contract Manufacturing Strategies: Market developments, technology transfer and key success factors

  • $ 3 835
  • May 2008
  • 165 pages

Contract Manufacturing StrategiesDrug manufacturing now typically accounts for 25% of company costs and achieving agility in the production process has become essential for pharma companies hoping to align their supply chains with constant shifts in global product demand. In addition to offering eff ...

Industries : Pharmaceutical

Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments

Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments

  • $ 3 835
  • June 2008
  • 175 pages

Leading Drug Delivery Companies and TechnologiesCompetitive landscape, company profiles and technological developmentsBusiness Intelligence for the Pharmaceutical IndustryBusiness Insights' portfolio of healthcare management reports is designed to help you make well informed and timely business deci ...

Industries : Pharmaceutical

Monoclonal Antibodies Report: 2008 Update - Detailed analysis of the monoclonal antibody segment, encompassing market dynamics, key therapy areas, technology and target types through to 2013, evaluating the strategies companies are using to capitalize on

Monoclonal Antibodies Report: 2008 Update - Detailed analysis of the monoclonal antibody segment, encompassing market dynamics, key therapy areas, technology and target types through to 2013, evaluating the strategies companies are using to capitalize on

  • $ 7 600
  • June 2008
  • 363 pages

IntroductionThe report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2013 and assessing trends by product, company, therapy area, technology and target type. It also provides an insight into the direction of mAb technology ev ...

Industries : Pharmaceutical

Pricing & Reimbursement - Seven Major Markets Update

Pricing & Reimbursement - Seven Major Markets Update

  • $ 5 700
  • May 2008
  • 119 pages

IntroductionGovernments and payers across the seven major markets are implementing cost-cutting initiatives to combat escalating healthcare costs, putting even greater pressure on pharma companies. In addition to the credit crunch, ever fewer novel products are coming to market, contributing to the ...

Industries : Pharmaceutical

Pipeline Insight: Non-insulin antidiabetics – Incretin mimetics – leaders in a diverse pipeline

Pipeline Insight: Non-insulin antidiabetics – Incretin mimetics – leaders in a diverse pipeline

  • $ 11 400
  • May 2008
  • 294 pages

IntroductionDatamonitor expects incretin mimetics to emerge as a major new therapeutic class in non-insulin antidiabetics, driven by an explosion in the patient population, safety fears surrounding established therapies and significant unmet patient needs.ScopeComprehensive analysis of the current n ...

Industries : Pharmaceutical

World Regenerative Medicine Market

World Regenerative Medicine Market

  • $ 3 950
  • April 2008
  • 383 pages

This report analyzes the worldwide markets for Regenerative Medicine in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, and Europe. Annual forecasts are provided for each region for the period of 2003 through 2015. The report profiles 106 companies including ...

Industries : Pharmaceutical

World Ophthalmic Pharmaceutical Drugs Market

World Ophthalmic Pharmaceutical Drugs Market

  • $ 3 950
  • April 2008
  • 523 pages

This report analyzes the worldwide markets for Opthalmic Pharmaceutical Drugs in US$ Million. The major therapeutic categories analyzed are Glaucoma, Anti-allergy, Anti-infective, Dry Eye, Anti-inflammation, Back of Eye, and Others. The report provides separate comprehensive analytics for the US, Ca ...

Industries : Pharmaceutical

24/7 Customer Service

Contact Clare now !

Related industries

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.